Stockholders’ Permanent and Temporary Equity (Details Narrative)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
11 Months Ended |
12 Months Ended |
|
|
|
|
|
|
Mar. 10, 2023
USD ($)
$ / shares
shares
|
Feb. 20, 2023
USD ($)
|
Jan. 27, 2023
USD ($)
$ / shares
shares
|
Dec. 31, 2022
USD ($)
$ / shares
shares
|
Dec. 12, 2022
$ / shares
shares
|
Dec. 12, 2022
$ / shares
shares
|
Dec. 06, 2022
USD ($)
$ / shares
shares
|
Sep. 22, 2022
$ / shares
|
Sep. 16, 2022
USD ($)
$ / shares
shares
|
Aug. 31, 2022
USD ($)
$ / shares
|
Jul. 08, 2022
USD ($)
$ / shares
shares
|
May 10, 2022
$ / shares
|
Mar. 31, 2022
USD ($)
$ / shares
shares
|
Dec. 13, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2022
USD ($)
$ / shares
shares
|
Mar. 31, 2023
USD ($)
$ / shares
shares
|
Mar. 31, 2022
USD ($)
$ / shares
|
Dec. 12, 2022
USD ($)
$ / shares
shares
|
Dec. 31, 2022
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 13, 2022
$ / shares
|
Dec. 31, 2020
shares
|
Dec. 15, 2020
shares
|
Apr. 18, 2019
$ / shares
shares
|
Dec. 15, 2015
$ / shares
shares
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued |
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock value | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 395,200
|
|
|
|
|
|
|
|
|
|
| Financial Designation, Predecessor and Successor [Fixed List] |
|
|
|
Successor
|
|
|
|
|
|
|
|
|
|
|
Successor
|
Successor
|
Predecessor
|
Predecessor
|
Successor
|
Predecessor
|
|
|
|
|
|
| Stock based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 56,333
|
$ 287,461
|
|
$ 3,524,802
|
|
$ 4,245,463
|
|
|
|
|
|
| Unrecognized stock-based compensation expense | $ |
|
|
|
$ 2,957,047
|
|
|
|
|
|
|
|
|
|
|
$ 2,957,047
|
$ 1,595,639
|
|
|
$ 2,957,047
|
|
|
|
|
|
|
| weighted average period |
|
|
|
|
|
1 year 7 months 6 days
|
|
|
|
|
|
|
|
|
|
1 year 7 months 6 days
|
|
|
|
|
|
|
|
|
|
| Weighted average remaining life, granted options |
ten-year
|
|
ten-year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options outstanding |
13,000
|
|
100,000
|
1,993,235
|
|
|
|
|
|
|
|
|
|
|
1,993,235
|
2,106,235
|
|
|
1,993,235
|
|
|
|
|
|
|
| Aggregate grant date value | $ |
$ 23,770
|
|
$ 184,426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average remaining life, vested options |
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options outstanding, exercise price | $ / shares |
$ 2.26
|
|
$ 2.11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average remaining life, vested options |
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of registration delay payments |
|
1.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
2.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Registration delay cash payment | $ |
|
$ 398,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
110,000,000
|
|
|
|
|
|
|
|
|
|
|
110,000,000
|
110,000,000
|
|
|
110,000,000
|
|
|
|
|
|
|
| Common stock, par value | $ / shares |
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
1,000,000
|
|
|
1,000,000
|
1,000,000
|
|
|
|
|
|
| Preferred stock, par value | $ / shares |
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
| Share price, per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.04
|
|
|
|
|
| Additional paid in capital | $ |
|
|
|
$ 104,583,271
|
|
|
|
|
|
|
|
|
|
|
$ 104,583,271
|
$ 105,562,569
|
|
|
$ 104,583,271
|
|
|
|
|
|
|
| Common stock exchanged during acquisition |
|
|
|
|
331,331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price share | $ / shares |
|
|
|
$ 11.50
|
|
|
|
|
|
|
|
|
|
|
$ 11.50
|
|
|
|
$ 11.50
|
|
|
|
|
|
|
| Number of options outstanding |
|
|
|
1,993,235
|
1,993,235
|
1,993,235
|
|
|
|
|
|
|
|
|
1,993,235
|
2,106,235
|
|
1,993,235
|
1,993,235
|
|
|
|
|
|
|
| Shares issued, price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.00
|
|
|
|
$ 3.00
|
|
|
$ 3.25
|
|
|
|
|
|
| Satisfaction of company liabilities | $ |
|
|
|
$ 5,062,000
|
|
|
|
|
|
|
|
|
|
|
$ 5,062,000
|
|
|
|
$ 5,062,000
|
|
|
|
|
|
|
| Share exchange ration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.037
|
|
|
|
5.037
|
|
|
|
|
|
|
| Company valuation | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 85,000,000
|
|
|
|
|
|
|
| Replacement warrants exercisable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
Replacement Warrants include (a) exercisable warrants to purchase 1,271,904 shares of Successor common stock with an exercise price
of $6.90 per share and with an expiration date of December 12, 2027, which replace the warrants that were issued by the Predecessor
to its Series A Preferred Stock holders upon the automatic conversion of their Predecessor Series A Preferred Stock into Predecessor
common stock and Predecessor Series A Warrants upon the closing of the Business Combination (see Note 11 – Stockholders’
Permanent and Temporary Equity – Automatic Conversion of Predecessor Series A Preferred Stock); (b) warrants to purchase 104,704
shares of Successor common stock with an exercise price of $5.03 per share which replace the warrants that were issued by the Predecessor
to a strategic partner (see Note 10 – Commitments and Contingencies – License Agreements – L&F Research LLC),
of which warrants to purchase 34,901 shares are exercisable until they expire on or about January 6, 2025, while the remainder vest
upon the achievement of certain milestones and expire five years following the achievement of those milestones; and (c) exercisable
warrants to purchase 323,026 shares of Successor common stock with an exercise price of $11.58 per share and with various expiration
dates through April 17, 2024 which replace the warrants that were issued by the Predecessor to certain purchasers of convertible
notes, certain brokers and a strategic partner in conjunction with entering into a license agreement (see Note 10 – Commitments
and Contingencies – License Agreements – InflamaCORE).
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options outstanding |
|
|
|
1,993,235
|
|
|
|
|
|
|
|
|
|
|
1,993,235
|
|
|
|
1,993,235
|
|
|
|
|
|
|
| Share exchange ration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.037
|
|
|
|
|
|
|
| Options Held [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options outstanding |
|
|
|
1,993,235
|
|
|
|
|
|
|
|
|
|
|
1,993,235
|
|
|
|
1,993,235
|
|
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable warrants |
|
|
|
863,500
|
|
|
|
|
|
|
|
|
|
|
863,500
|
|
|
|
863,500
|
|
|
|
|
|
|
| Replacement Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
1,699,633
|
|
|
|
|
|
|
|
|
|
|
1,699,633
|
|
|
|
1,699,633
|
|
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price, per share | $ / shares |
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
| Warrant exercise price share | $ / shares |
|
|
|
11.50
|
|
|
|
|
|
|
|
|
|
|
11.50
|
|
|
|
11.50
|
|
|
|
|
|
|
| Shares issued, price per share | $ / shares |
|
|
|
1,000
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
$ 1,000
|
|
|
|
|
|
|
| Share exchange ration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.037
|
|
|
|
|
|
|
| Closing price of common stock | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
|
|
|
|
|
|
|
|
|
|
| Larkspur Larkspur Merger Sub Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock exchanged during acquisition |
|
|
|
|
65,783
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Larkspur Larkspur Merger Sub Inc [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price share | $ / shares |
|
|
|
$ 11.50
|
|
|
|
|
|
|
|
|
|
|
$ 11.50
|
|
|
|
$ 11.50
|
|
|
|
|
|
|
| Shares of common stock |
|
|
|
6,065,573
|
|
|
|
|
|
|
|
|
|
|
6,065,573
|
|
|
|
6,065,573
|
|
|
|
|
|
|
| Put Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional paid in capital | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 331
|
|
|
|
|
|
|
|
|
|
|
|
| P I P E Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
863,500
|
|
|
|
|
|
|
|
|
|
| Preferred stock price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
| Net proceeds | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8,635,000
|
|
|
|
|
|
|
|
|
|
| Series A Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,635
|
|
|
|
|
|
|
|
|
|
| Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8,635,000
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
8,635
|
|
|
|
|
|
|
|
|
|
|
8,635
|
8,635
|
|
|
8,635
|
|
|
|
|
|
|
| Preferred stock, shares designated |
|
|
|
8,635
|
|
|
|
|
|
|
|
|
|
|
8,635
|
8,635
|
|
|
8,635
|
|
|
|
|
|
|
| Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,635
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
5,062
|
|
|
|
|
|
|
|
|
|
|
5,062
|
5,062
|
|
|
5,062
|
5,062
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
863,500
|
|
|
|
|
|
|
|
|
|
|
863,500
|
|
|
|
863,500
|
|
|
|
|
|
|
| Shares issued, price per share | $ / shares |
|
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
|
|
$ 1,000
|
|
|
|
|
|
|
| Preferred stock, shares designated |
|
|
|
5,062
|
|
|
|
|
|
|
|
|
|
|
5,062
|
5,062
|
|
|
5,062
|
5,062
|
|
|
|
|
|
| Shares conversion price | $ / shares |
|
|
|
$ 10.00
|
|
|
|
|
|
|
|
|
|
|
$ 10.00
|
|
|
|
$ 10.00
|
|
|
|
|
|
|
| Series B Preferred Stock [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares conversion price | $ / shares |
|
|
|
$ 7.00
|
|
|
|
|
|
|
|
|
|
|
$ 7.00
|
|
|
|
$ 7.00
|
|
|
|
|
|
|
| Predecessor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock value | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Financial Designation, Predecessor and Successor [Fixed List] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor
|
Predecessor
|
|
Predecessor
|
|
|
|
|
|
| Stock based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,941,746
|
|
|
|
|
|
|
|
|
| Aggregate grant date value | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,271,992
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
75,000,000
|
75,000,000
|
|
|
|
|
|
|
|
|
|
|
|
75,000,000
|
|
75,000,000
|
|
|
|
|
|
| Common stock, par value | $ / shares |
|
|
|
|
$ 0.00001
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
$ 0.00001
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
5,000,000
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
| Preferred stock, par value | $ / shares |
|
|
|
|
$ 0.00001
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
|
|
|
| Additional paid in capital | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 40,065,109
|
|
|
|
|
|
| Proceeds from related party debt | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
$ 3,150,000
|
|
|
|
|
|
| Placement agent fees | $ |
|
|
|
|
|
|
$ 2,000
|
|
$ 16,000
|
|
$ 21,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Incremental fair value of stock and warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 331,200
|
|
|
|
|
|
|
| Aggregate common stock of warrant exercise price share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 3.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant, Exercise Price, Decrease | $ / shares |
|
|
|
|
|
|
|
$ 1.37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,039,348
|
|
8,755,179
|
|
|
|
| Share exchange |
|
|
|
|
6,406,210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400,000
|
|
| Share exchange ration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.037
|
|
|
|
|
|
|
|
| Company valuation | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 85,000,000
|
|
|
|
|
|
|
|
| Predecessor [Member] | Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options outstanding |
|
|
|
|
10,039,348
|
10,039,348
|
|
|
|
|
|
|
|
|
|
|
|
10,039,348
|
|
|
|
|
|
|
|
| Share exchange ration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.037
|
|
|
|
|
|
|
|
| Predecessor [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
| Warrant exercise price share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 3.20
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.30
|
$ 1.00
|
| Aggregate common stock of warrant exercise price share | $ / shares |
|
|
|
|
$ 6.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
351,578
|
6,406,210
|
6,406,210
|
|
|
|
|
|
|
|
|
351,578
|
|
|
6,406,210
|
351,578
|
|
|
|
175,789
|
|
351,579
|
| Warrant exchange |
|
|
|
|
1,271,904
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Predecessor [Member] | Second Amendment Securities [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Incremental fair value of stock and warrants | $ |
|
|
|
|
|
|
|
|
|
$ 9,684,637
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Predecessor [Member] | Predecessor Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options outstanding |
|
|
|
|
8,560,561
|
8,560,561
|
|
|
|
|
|
|
|
|
|
|
|
8,560,561
|
|
|
|
|
|
|
|
| Predecessor [Member] | Larkspur Larkspur Merger Sub Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share exchange |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,845,335
|
|
|
|
|
|
|
| Predecessor [Member] | Put Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Put option purchase of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
331,331
|
|
|
|
|
|
|
|
|
|
|
|
| Share price, per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.00
|
|
|
|
|
|
|
|
|
|
|
|
| Predecessor [Member] | Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 392,301
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from related party debt | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds | $ |
|
|
|
|
|
|
$ 548,805
|
|
$ 700,000
|
|
$ 296,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock conversion price per share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 2.78
|
|
3.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock conversion price per share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 1.19
|
|
$ 2.78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options outstanding |
|
|
|
|
2,427,832
|
2,427,832
|
|
|
|
|
|
|
|
|
|
|
|
2,427,832
|
|
|
|
|
|
|
|
| Predecessor [Member] | Series A Preferred Stock [Member] | Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock sold |
|
|
|
|
|
|
174,776
|
|
222,929
|
|
94,393
|
|
133,541
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock price per share | $ / shares |
|
|
|
|
|
|
$ 3.14
|
|
$ 3.14
|
|
$ 3.14
|
|
$ 3.14
|
|
|
|
$ 3.14
|
|
|
|
|
|
|
|
|
| Research and Development Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,808
|
$ 49,455
|
|
$ 673,160
|
|
$ 944,525
|
|
|
|
|
|
| Research and Development Expense [Member] | Predecessor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 307,838
|
|
|
|
|
|
|
|
|
| General and Administrative Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 48,525
|
$ 238,006
|
|
$ 2,851,642
|
|
$ 3,300,938
|
|
|
|
|
|
| General and Administrative Expense [Member] | Predecessor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,633,908
|
|
|
|
|
|
|
|
|
| Marketing Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
130,000
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock value | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 395,200
|
|
|
|
|
|
|
|
|
|
| 2014 Equity Incentive Plan [Member] | Predecessor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
|
|
|
| Equity incentive plan, description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The number of shares of common stock available for issuance under the 2014 Plan shall
automatically increase on the first trading day of January each calendar year during the term of the 2014 Plan, beginning with calendar
year 2019, by an amount equal to five percent (5%) of the total number of shares of common stock outstanding on the last trading day
in December of the immediately preceding calendar year, but in no event shall any such annual increase exceed 100,000 shares of common
stock.
|
|
|
|
|
|
| Common stock future issuance |
|
|
|
|
45,652
|
45,652
|
|
|
|
|
|
|
|
|
|
|
|
45,652
|
|
|
|
|
|
|
|
| 2022 Omnibus Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
1,089,831
|
|
|
|
|
|
|
|
|
|
|
1,089,831
|
|
|
|
1,089,831
|
|
|
|
|
|
|
| Common stock future issuance |
|
|
|
1,089,831
|
|
|
|
|
|
|
|
|
|
|
1,089,831
|
|
|
|
1,089,831
|
|
|
|
|
|
|